These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10069875)

  • 81. Glucocorticoid-resistant asthma.
    Loke TK; Sousa AR; Corrigan CJ; Lee TH
    Curr Allergy Asthma Rep; 2002 Mar; 2(2):144-50. PubMed ID: 11892094
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Asthma refractory to glucocorticoids: the role of newer immunosuppressants.
    Corrigan CJ
    Am J Respir Med; 2002; 1(1):47-54. PubMed ID: 14720075
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Primary care provider preferences for glucocorticoid management of acute asthma exacerbations in children.
    Navanandan N; Moran E; Smith H; Hoch H; Mistry RD
    J Asthma; 2021 Apr; 58(4):547-553. PubMed ID: 31877252
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Combination oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema.
    Majeski C; Taher M; Grewal P; Dytoc M; Lauzon G
    J Cutan Med Surg; 2005 Jun; 9(3):99-104. PubMed ID: 16392012
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [The analysis of the factors influencing the development of glucocorticoid resistance in the etiopathogenesis of severe bronchial asthma].
    Panek M; Pietras T; Kupryś-Lipińska I; Górski P; Kuna P; Szemraj J
    Postepy Biochem; 2010; 56(4):373-82. PubMed ID: 21473041
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose.
    Wasilewska A; Zoch-Zwierz W
    J Pediatr Endocrinol Metab; 2005 Aug; 18(8):799-806. PubMed ID: 16200847
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma.
    Mazer BD; Gelfand EW
    J Allergy Clin Immunol; 1991 May; 87(5):976-83. PubMed ID: 2026848
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis.
    Wegner B; Ahmed I
    Clin Neurol Neurosurg; 2002 Dec; 105(1):3-8. PubMed ID: 12445915
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Treatment of late-onset asthma with fluconazole.
    Ward GW; Woodfolk JA; Hayden ML; Jackson S; Platts-Mills TA
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):541-6. PubMed ID: 10482825
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Steroid resistance in severe asthma: current mechanisms and future treatment.
    Durham A; Adcock IM; Tliba O
    Curr Pharm Des; 2011; 17(7):674-84. PubMed ID: 21406059
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Why do some asthma patients respond poorly to glucocorticoid therapy?
    Henderson I; Caiazzo E; McSharry C; Guzik TJ; Maffia P
    Pharmacol Res; 2020 Oct; 160():105189. PubMed ID: 32911071
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Racial differences in T-lymphocyte response to glucocorticoids.
    Federico MJ; Covar RA; Brown EE; Leung DY; Spahn JD
    Chest; 2005 Feb; 127(2):571-8. PubMed ID: 15705998
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chronic Stress and Glucocorticoid Receptor Resistance in Asthma.
    Palumbo ML; Prochnik A; Wald MR; Genaro AM
    Clin Ther; 2020 Jun; 42(6):993-1006. PubMed ID: 32224031
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A rare case of refractory asthma managed with azathioprine.
    Kalra SS; Lamia I
    J Asthma; 2020 Sep; 57(9):1039-1041. PubMed ID: 31164022
    [No Abstract]   [Full Text] [Related]  

  • 95. Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry.
    Sweeney J; Brightling CE; Menzies-Gow A; Niven R; Patterson CC; Heaney LG;
    Thorax; 2012 Aug; 67(8):754-6. PubMed ID: 22581823
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immunomodulatory effects of intravenous immunoglobulin in severe steroid-dependent asthma.
    Mazer BD; Giclas PC; Gelfand EW
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S156-63. PubMed ID: 2791344
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The effect of dapsone in steroid-dependent asthma.
    Berlow BA; Liebhaber MI; Dyer Z; Spiegel TM
    J Allergy Clin Immunol; 1991 Mar; 87(3):710-5. PubMed ID: 2005324
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Response to glucocorticoid treatment in asthma. The role of alpha and beta isoforms of the glucocorticoid receptor].
    Torrego A; Pujols L; Picado C
    Arch Bronconeumol; 2002 Sep; 38(9):436-40. PubMed ID: 12237016
    [No Abstract]   [Full Text] [Related]  

  • 99. Assessment of inflammation based on the release of oxygen radicals by granulocytes in chronic uncontrolled asthma.
    Sartorelli CF; Rehder J; Condino Neto A; Vilela MM
    J Pediatr (Rio J); 2009; 85(2):143-8. PubMed ID: 19319447
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Functional proteomics for the characterization of impaired cellular responses to glucocorticoids in asthma.
    Pazdrak K; Kurosky A
    Adv Exp Med Biol; 2014; 795():255-70. PubMed ID: 24162914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.